Induction and Modulation of Hepatic Preneoplasia and Neoplasia in the Rat by Dehydroepiandrosterone

Toxicologic Pathology

Volumn 31, Issue 1, 2003, Pages 103-112

  Mayer, Doris ^a   Forstner, Klaus ^a   Kopplow, Kathrin ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

cell signaling; cellular lineages; cytokines; Dehydroepiandrosterone; energy metabolism; growth inhibition; hepatocarcinogenesis; N nitrosomorpholine; preneoplasia; rat liver; tumor promotion

Indexed keywords

AMPHOPHILE; ANDROGEN; CORTICOSTEROID; CYTOKINE; ESTROGEN; PEROXISOME PROLIFERATOR; PRASTERONE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; BASOPHIL; BIOSYNTHESIS; CANCER GROWTH; CELL LINEAGE; CELL METABOLISM; CELL PROLIFERATION; CONFERENCE PAPER; CONTROLLED STUDY; ENERGY CONSUMPTION; GLYCOGENOLYSIS; GROWTH INHIBITION; LIVER; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; TUMOR PROMOTION;

ANIMALS; COCARCINOGENESIS; DEHYDROEPIANDROSTERONE; LIVER; LIVER NEOPLASMS, EXPERIMENTAL; NITROSAMINES; PRECANCEROUS CONDITIONS; RATS;

ANIMALIA;

EID: 0037258775     PISSN: 01926233     EISSN: None     Source Type: Journal    
DOI: 10.1080/01926230390173914     Document Type: Article

References (45)

1. Bannasch P. (1996). Pathogenesis of hepatocellular carcinoma: Sequential cellular, molecular, and metabolic changes. In: Progress in Liver Diseases, Vol XIV, Boyer JL, Ockner RK (eds). WB Saunders Company, Philadelphia, pp 161-197.
2. Bannasch P., Klimek F., Mayer D. (1997). Early bioenergetic changes in hepatocarcinogenesis: Preneoplastic phenotypes mimic responses to insulin and thyroid hormone. J Bioenerg Biomemb 29: 303-313.
3. Bannasch P., Metzger C., Mayer D. (2000). Hepatocarcinogenesis by dehydroepiandrosterone. I. Sequential cellular changes during neoplastic develoment. In: Dehydroepiandrosterone (DHEA). Biochemical, Physiological and Clinical Aspects, Regelson W, Kalimi M (eds). Walter de Gruyter, Berlin, pp 237-249.
4. Bannasch P., Nehrbass D., Kopp-Schneider A. (2001). Significance of hepatic preneoplasia for cancer prevention. In: Biomarkers in Cancer Chemoprevention, Miller AB, Bartsch H, Boffetta P, Dragsted L, Vainio H (eds). IARC Scientific Publications No. 154, International Agency for Research on Cancer, Lyon, pp 223-240.
5. Bellino FL, Daynes RA, Hornsby PJ, Lavrin DH, Nestler JE (eds) (1995). Dehydroepiandrosterone and Aging. Ann NY Acad Sci 774: 1-350.
6. Feo F., Daino L., Seddaiu MA, Simile MM, Pascale RM, McKeating JA, Davliakos GP, Sudol KS, Melhem MF, Rao KN (1991). Differential effects of dehydroepiandrosterone and deoxyribonucleotides on DNA synthesis and de novo cholesterogenesis in hepatocarcinogenesis in rat. Carcinogenesis 12: 1581-1586.
7. Feo F., Pascale RM, Simile MM, De Miglio MR (2000). Role of dehydroepiandrosterone in experimental and human carcinogenesis. In: Dehydroepiandrosterone (DHEA), Biochemical, Physiological and Clinical Aspects, Kalimi M, Regelson W (eds). Walter de Gruyter, Berlin, pp 215-236.
8. Garcea R., Daino L., Frassetto S., Cozzolino P., Ruggiu ME, Vannini MG, Pascale R., Lenzerini L., Simile MM, Puddu M., Feo F. (1988). Reversal by ribo- and deoxyribonucleosides of dehydroepiandrosterone-induced inhibition of enzyme altered foci in the liver of rats subjected to the initiation-selection process of experimental hepatocarcinogenesis. Carcinogenesis 9: 931-938.
9. Garcea R., Daino L., Pascale R., Frassetto S., Cozzolino P., Ruggiu ME, Feo F. (1987). Inhibition by dehydroepiandrosterone of liver preneoplastic foci formation in rats after initiation-selection in experimental carcinogenesis. Toxicol Pathol 15: 164-169.
10. Hayashi F., Tamura H., Yamada J., Kasai H., Suga T. (1994). Characteristics of the hepatocarcinogenesis caused by dehydroepiandrosterone, a peroxisome proliferator, in male F-344 rats. Carcinogenesis 15: 2215-2219.
11. Hobe G., Hillesheim HG, Schön R., Reddersen G., Knappe R., Bannasch P., and Mayer D. (1994). Sex differences in dehydroepiandrosterone metabolism in the rat: Different plasma levels following ingestion of DHEA-supplemented diet and different metabolite patterns in plasma, bile and urine. Horm Metab Res 26: 326-329.
12. Kalimi M, Regelson W (eds) (1990). The Biologic Role of Dehydroepiandrosterone (DHEA). Walter de Gruyter, Berlin, New York.
13. Kalimi M, Regelson W (eds) (2000). Dehydroepiandrosterone (DHEA). Biochemical, Physiological and Clinical Aspects. Walter de Gruyter, Berlin, New York.
14. Labrie C., Simard J., Zhao HF, Bélanger A., Pelletier G., Labrie F. (1989). Stimulation of androgen-dependent gene expression by the adrenal precursors dehydroepiandrosterone and androstenedione in the rat ventral prostate. Endocrinology 124: 2745-2754.
15. Mayer D. (1998.) Carcinogenic and anticarcinogenic effects of dehydroepiandrosterone in the liver of male and female rats. Aging Male 1: 56-66.
16. Mayer D. (2002). DHEA effects on liver. In: DHEA and the Brain, Morfin R (ed). Harwood Academic Publishers, London, pp 81-100.
17. Mayer D., Metzger C., Bannasch P. (2000). Hepatocarcinogenesis by dehydroepiandrosterone. II. Biochemical and molecular changes during neoplastic development. In: Dehydroepiandrosterone (DHEA). Biochemical, Physiological and Clinical Aspects, Regelson W, Kalimi M (eds). Walter de Gruyter, Berlin, pp 251-260.
18. Mayer D., Metzger C., Leonetti P., Beier K., Benner A., Bannasch P. (1998). Differential expression of key enzymes of energy metabolism in preneoplastic and neoplastic rat liver lesions induced by N-nitrosomorpholine and dehydroepiandrosterone. Int J Cancer (Pred Oncol) 79: 232-240.
19. Mayer D., Metzger C., Nehrbass D., Bannasch P. (1998). Hepatocarcinogenesis by dehydroepiandrosterone. Curr Topics Steroid Res 1: 135-144.
20. Mayer D., Reuter S., Hoffmann H., Bocker T., Bannasch P. (1996). Dehydroepiandrosterone reduces expression of glycolytic and gluconeogenic enzymes in the liver of male and female rats. Int J Oncol 8: 1069-1078.
21. Mayer D., Weber E., Moore MA, Letsch I., Filsinger E., Bannasch P. (1988). Dehydroepiandrosterone (DHEA) induced alterations in rat liver carbohydrate metabolism. Carcinogenesis 11: 2039-2049.
22. McIntosh MK, Berdanier C. (1992). Influence of DHEA on the thyroid hormone status of BHE/cdb rats. J Nutr Biochem 3: 194-199.
23. Metzger C., Bannasch P., Mayer D. (1997). Enhancement and phenotypic modulation of N-nitrosomorpholine-induced hepatocarcinogenesis by dehydroepiandrosterone. Cancer Lett 121: 125-131.
24. Metzger C., Mayer D., Hobe G., Hoffmann H., Bocker T., Benner A., Bannasch P. (1995). Sequential appearance and ultrastructure of amphophilic cell foci, adenomas, and carcinomas in the liver of male and female rats treated with dehydroepiandrosterone. Toxicol Pathol 23: 591-605.
25. Moore MA, Thamavit W., Tsuda H., Sato K., Ichihara A., Ito N. (1986). Modifying influence of dehydroepiandrosterone on the development of dihydroxydi-N-propylnitrosamine-initiated lesions in the thyroid, lung and liver of F344 rats. Carcinogenesis 7: 311-316.
26. Moore MA, Weber E., Mayer D., Bannasch P. (1989). Adrenal cortical foci and nodules in Sprague-Dawley rats treated with N-nitrosomorpholine. Light and electron microscopic findings. Virchows Arch B Cell Pathol Incl Mol Pathol 57: 91-97.
27. Nehrbass D., Klimek F., Bannasch P. (1998). Overexpression of insulin receptor substrate-1 emerges early in hepatocarcinogenesis and elicits preneoplastic hepatic glycogenosis. Am J Pathol 152: 341-345.
28. Nehrbass D., Klimek F., Bannasch P., Mayer D. (1999). Insulin receptor substrate-1 is overexpressed in glycogenotic but not in amphophilic preneoplastic hepatic foci induced in rats by N-nitrosomorpholine and dehydroepiandrosterone. Cancer Lett 140: 75-79.
29. Orner GA, Hendricks JD, Arbogast D., Williams DE (1998). Modulation of aflatoxin-B1 hepatocarcinogenesis in trout by dehydroepiandrosterone: Initiation/post-initiation and latency effects. Carcinogenesis 19: 161-167.
30. Orner GA, Mathews C., Hendricks JD, Carpenter HM, Bailey GS, Williams DE (1995). Dehydroepiandrosterone is a complete hepatocarcinogen and potent tumor promoter in the absence ofperoxisome proliferation in rainbow trout. Carcinogenesis 16: 2893-2898.
31. Rao MS, Reid B., Ide H., Subbarao V., Reddy, JK (1994). Dehydroepiandrosterone-induced peroxisome proliferation in the rat: Evaluation of sex differences. Proc Soc Exp Biol Med 207: 186-190.
32. Rao MS, Subbarao V., Kumar S., Yeldandi AV, Reddy JK (1992). Phenotypic properties of liver tumors induced by dehydroepiandrosterone in F-344 rats. Jpn J Cancer Res 83: 1179-1183.
33. Rao MS, Subbarao V., Yeldandi AV, Reddy JK (1992). Hepatocarcinogenicity of dehydroepiandrosterone in the rat. Cancer Res 52: 2977-2979.
34. Schwartz AG, Whitcomb JM, Nyce JW, Lewbart ML, Pashko LL (1988). Dehydroepiandrosterone and structural analogs: A new class of cancer chemopreventive agents. Adv Cancer Res 51: 391-424.
35. Simile A., Pascale RM, De Miglio MR, Nufris A., Daino L., Seddaiu MA, Muroni MR, Rao KN, Feo F. (1995). Inhibition by dehydroepiandrosterone of growth and progession of persistent liver nodules in experimental rat liver carcinogenesis. Int J Cancer 62: 210-215.
36. Song MK, Grieco D., Rall JE, Nikodem VM (1989). Thyroid hormone-mediated transcriptional activation of the rat liver malic enzyme gene by dehydroepiandrosterone. J Biol Chem 264: 18981-18985.
37. Sourla A., Martel C., Labrie C., Labrie F. (1998). Almost exclusive androgenic action of dehydroepiandrosterone in the rat mammary gland. Endocrinology 139: 753-764.
38. Swierczynski J., Mayer D. (1996). Increase of lipid peroxidation in rat liver mitochondria by dehydroepiandrosterone (DHEA) feeding. J Steroid Biochem Molec Biol 58: 599-603.
39. Swierczynski J., Bannasch P., Mayer D. (1996). Increase of lipid peroxidation in rat liver microsomes by dehydroepiandrosterone (DHEA) feeding. Biochim Biophys Acta 1315: 193-198.
40. Swierczynski J., Kochan Z., Mayer D. (1997). Dietary α-tocopherol prevents DHEA-induced lipid peroxidation in rat liver microsomes and mitochondria. Toxicol Lett 91: 129-136.
41. Swierczynski J., Mayer D. (1998). Vitamin E prevents induction of carbonyl group formation in microsomal protein by dehydroepiandrosterone. Nutr Cancer 32: 101-106.
42. Thornton M., Moore MA, Ito N. (1989). Modifying influence of dehydroepiandrosterone or butylated hydroxytoluene treatment on initiation and development stages of azaserine-induced acinar pancreatic lesions in the rat. Carcinogenesis 10: 407-410.
43. Weber E., Moore MA, Bannasch P. (1988). Phenotypic modulation of hepatocarcinogenesis and reduction in N-nitrosomorpholine-induced hemangiosarcoma and adrenal lesion development in Sprague-Dawley rats by dehydroepiandrosterone. Carcinogenesis 9: 1191-1195.
44. Weber E., Moore MA, Bannasch P. (1988). Enzyme histochemical and morphological phenotype of amphophilic foci and amphophilic/tigroid cell adenomas in rat liver after combined treatment with dehydroepiandrosterone and N-nitrosomorpholine. Carcinogenesis 9: 1049-1054.
45. Yen SS (2001). Dehydroepiandrosterone sulfate and longevity: New clues for an old friend. Proc Natl Acad Sci USA 98: 8167-8169.